Saturday, October 10, 2015 2:51:45 PM
Sorry, my first paragraph, last sentence should say "so it is interesting that that hasn't happened yet".
Thanks!
Thanks!
All my posts, comments, and investments are not to be considered investment advice in any way.
Recent BNTC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 12:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:09:20 PM
- Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/14/2026 12:00:00 PM
- Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting • GlobeNewswire Inc. • 04/28/2026 11:00:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/20/2026 08:03:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:09:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 01:07:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/11/2026 05:15:29 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2026 09:02:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 09:19:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2025 10:27:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2025 10:37:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2025 10:36:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2025 10:35:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:31:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 10:05:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 11:06:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 02:29:10 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2025 02:26:08 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/05/2025 10:17:07 PM
- Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy • IH Market News • 11/03/2025 02:35:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 12:11:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/14/2025 09:00:08 PM
